GlassScriptPhysician profile
David Hamilton Gibbs
NPI 1760451272
$882.94
in general payments reported to CMS, 2019-2025
22 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $112 · 2021: $71.15 · 2022: $86.80 · 2023: $122 · 2024: $91.15 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $172.65 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.77 | 2019-2024 | Xifaxan |
| Tela Bio, INC. | $87.32 | 2019 | |
| Organogenesis INC. | $51.32 | 2023 | Puraply |
| Neuraxis, INC. | $46.07 | 2025 | |
| Janssen Biotech, INC. | $44.61 | 2022-2025 | Tremfya |
| Braintree Laboratories, INC. | $39.23 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.22 | 2019-2020 | |
| Ethicon US, LLC | $32.49 | 2019 | |
| Mallinckrodt Enterprises LLC | $28.29 | 2019 | |
| Thd America, INC. | $26.53 | 2022-2023 | |
| Micro-Tech Endoscopy USA, INC. | $24.69 | 2023 | Lesion Hunter |
| Axonics, INC. | $23.44 | 2021 | |
| Ucb, INC. | $21.28 | 2019 | |
| Trevena, INC. | $21.10 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prescient Surgical | $17.36 | 2019 | |
| Aimmune Therapeutics, INC. | $16.06 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $14.25 | 2022 | |
| Solventum Corporation | $13.50 | 2024 | 3m Cavilon, Activ.A.C. |
| Mallinckrodt Hospital Products INC. | $13.23 | 2020 | |
| Daiichi Sankyo INC. | $13.07 | 2020 | |
| Alfasigma USA, INC. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gibbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.